Sandra Baos-Perez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum: MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction.
Journal: Frontiers in immunology
Published: November 28, 2023
Effects of Tofacitinib on Muscle Remodeling in Experimental Rheumatoid Sarcopenia.
Journal: International journal of molecular sciences
Published: July 24, 2023
MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction.
Journal: Frontiers in immunology
Published: March 24, 2023
Modulation of the Inflammatory Process by Hypercholesterolemia in Osteoarthritis.
Journal: Frontiers in medicine
Published: May 27, 2020
Targeting chronic innate inflammatory pathways, the main road to prevention of osteoarthritis progression.
Journal: Biochemical pharmacology
Published: January 14, 2019
Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis.
Journal: Journal of inflammation (London, England)
Published: October 18, 2018
Validation of Musculoskeletal Ultrasound in the Assessment of Experimental Gout Synovitis.
Journal: Ultrasound in medicine & biology
Published: January 11, 2018
Mediators and Patterns of Muscle Loss in Chronic Systemic Inflammation.
Journal: Frontiers in physiology
Published: December 20, 2017
Increased synovial lipodystrophy induced by high fat diet aggravates synovitis in experimental osteoarthritis.
Journal: Arthritis research & therapy
Published: September 13, 2017
Tofacitinib restores the inhibition of reverse cholesterol transport induced by inflammation: understanding the lipid paradox associated with rheumatoid arthritis.
Journal: British journal of pharmacology
Published: January 13, 2017
Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritis.
Journal: Scientific reports
Published: January 05, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026